Stay updated on Risankizumab Autoinjector Usability Clinical Trial
Sign up to get notified when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.

Latest updates to the Risankizumab Autoinjector Usability Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange Detected- The page footer now displays Revision: v3.4.2, replacing Revision: v3.4.1.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1. No substantive changes to study details or content are evident in the visible page.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page now includes a glossary toggle, capitalization tweaks to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), and a new revision indicator (v3.4.0) replacing the previous v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page revision tag was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA new consolidated Locations section lists study sites by state (Arizona, Arkansas, California, Connecticut, Florida, Kansas, Maryland, Michigan, Missouri, New Hampshire, North Carolina, Oregon, Pennsylvania, Texas, Washington, Wisconsin) and the revision is updated to v3.3.3.SummaryDifference2%

- Check91 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Risankizumab Autoinjector Usability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab Autoinjector Usability Clinical Trial page.